Study of KITE-363 or KITE-753 in Participants With Relapsed and/or Refractory B-cell Lymphoma
Clinical trial NCT04989803 · RECRUITING
Trial details
- NCT number
- NCT04989803
- Sponsor
- Kite, A Gilead Company
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-27
- Primary completion
- 2030-02-01
- Enrollment
- 247
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.